Sep 21 2018

​Will Garvin, shareholder in the firm's FDA/Biotechnology practice, talks about the legality of CBD during a panel discussion titled "Understanding the Fuzz: The Muddled Legal Landscape Regarding CBD" at the CBD Expo Tour 2018. Watch the discussion here.